Alzheimer's Disease and Small Vessel Disease Differentially Affect White Matter Microstructure.
Journal
Annals of clinical and translational neurology
ISSN: 2328-9503
Titre abrégé: Ann Clin Transl Neurol
Pays: United States
ID NLM: 101623278
Informations de publication
Date de publication:
16 May 2024
16 May 2024
Historique:
received:
18
03
2024
accepted:
09
04
2024
medline:
17
5
2024
pubmed:
17
5
2024
entrez:
17
5
2024
Statut:
aheadofprint
Résumé
Alzheimer's disease (AD) and cerebral small vessel disease (cSVD), the two most common causes of dementia, are characterized by white matter (WM) alterations diverging from the physiological changes occurring in healthy aging. Diffusion tensor imaging (DTI) is a valuable tool to quantify WM integrity non-invasively and identify the determinants of such alterations. Here, we investigated main effects and interactions of AD pathology, APOE-ε4, cSVD, and cardiovascular risk on spatial patterns of WM alterations in non-demented older adults. Within the prospective European Prevention of Alzheimer's Dementia study, we selected 606 participants (64.9 ± 7.2 years, 376 females) with baseline cerebrospinal fluid samples of amyloid β AD pathology, APOE-ε4, cSVD burden, and cardiovascular risk were all associated with WM integrity within several tracts. While limbic tracts were mainly impacted by AD pathology and APOE-ε4, commissural, associative, and projection tract integrity was more related to cSVD burden and cardiovascular risk. AD pathology and cSVD did not show any significant interaction effect. Our results suggest that AD pathology and cSVD exert independent and spatially different effects on WM microstructure, supporting the role of DTI in disease monitoring and suggesting independent targets for preventive medicine approaches.
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : EU/EFPIA Innovative Medicines Initiative (IMI)
ID : 115736
Organisme : Horizon 2020
ID : 115952
Informations de copyright
© 2024 The Authors. Annals of Clinical and Translational Neurology published by Wiley Periodicals LLC on behalf of American Neurological Association.
Références
Pichet Binette A, Theaud G, Rheault F, et al. Bundle‐specific associations between white matter microstructure and Aβ and tau pathology in preclinical Alzheimer's disease [Internet]. elife. 2021;10:e62929. doi:10.7554/eLife.62929
Tuladhar AM, van Norden AGW, de Laat KF, et al. White matter integrity in small vessel disease is related to cognition. Neuroimage Clin. 2015;7:518‐524.
Cuadrado‐Godia E, Dwivedi P, Sharma S, et al. Cerebral small vessel disease: a review focusing on pathophysiology, biomarkers, and machine learning strategies. J Stroke Cerebrovasc Dis. 2018;20(3):302‐320.
Desai MK, Mastrangelo MA, Ryan DA, Sudol KL, Narrow WC, Bowers WJ. Early oligodendrocyte/myelin pathology in Alzheimer's disease mice constitutes a novel therapeutic target. Am J Pathol. 2010;177(3):1422‐1435.
Chao LL, Decarli C, Kriger S, et al. Associations between white matter hyperintensities and β amyloid on integrity of projection, association, and limbic fiber tracts measured with diffusion tensor MRI. PLoS One. 2013;8(6):e65175.
Akoudad S, de Groot M, Koudstaal PJ, et al. Cerebral microbleeds are related to loss of white matter structural integrity. Neurology. 2013;81(22):1930‐1937.
Freeze WM, Jacobs HIL, Gronenschild EH, et al. White matter Hyperintensities potentiate hippocampal volume reduction in non‐demented older individuals with abnormal amyloid‐β. J Alzheimers Dis. 2017;55(1):333‐342.
Shirzadi Z, Schultz SA, Yau W‐YW, et al. Etiology of white matter hyperintensities in autosomal dominant and sporadic Alzheimer disease [Internet]. JAMA Neurol. 2023;80:1353‐1363. doi:10.1001/jamaneurol.2023.3618
Storsve AB, Fjell AM, Yendiki A, Walhovd KB. Longitudinal changes in white matter tract integrity across the adult lifespan and its relation to cortical thinning. PLoS One. 2016;11(6):e0156770.
Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)‐based white matter mapping in brain research: a review. J Mol Neurosci. 2008;34(1):51‐61.
Pålhaugen L, Sudre CH, Tecelao S, et al. Brain amyloid and vascular risk are related to distinct white matter hyperintensity patterns. J Cereb Blood Flow Metab. 2020;41:1162‐1174.
Vemuri P, Lesnick TG, Knopman DS, et al. Amyloid, vascular, and resilience pathways associated with cognitive aging. Ann Neurol. 2019;86(6):866‐877.
Aisen PS, Jimenez‐Maggiora GA, Rafii MS, Walter S, Raman R. Early‐stage Alzheimer disease: getting trial‐ready. Nat Rev Neurol. 2022;18(7):389‐399.
Wardlaw JM, Woodhouse LJ, Mhlanga II, et al. Isosorbide mononitrate and cilostazol treatment in patients with symptomatic cerebral small vessel disease: the lacunar intervention Trial‐2 (LACI‐2) randomized clinical trial. JAMA Neurol. 2023;80(7):682‐692.
Koops EA, Jacobs HIL. Untangling white matter fibre changes in Alzheimer's disease and small vessel disease. Brain. 2023;146(2):413‐415.
Ngandu T, Lehtisalo J, Solomon A, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at‐risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255‐2263.
Solomon A, Kivipelto M, Molinuevo JL, Tom B, Ritchie CW, EPAD Consortium. European prevention of Alzheimer's dementia longitudinal cohort study (EPAD LCS): study protocol. BMJ Open. 2019;8(12):e021017.
Ingala S, De Boer C, Masselink LA, et al. Application of the ATN classification scheme in a population without dementia: findings from the EPAD cohort [Internet]. Alzheimers Dement. 2021;17:1189‐1204. doi:10.1002/alz.12292
Wardlaw JM, Smith EE, Biessels GJ, et al. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration [Internet]. Lancet Neurol. 2013;12(8):822‐838. doi:10.1016/s1474‐4422(13)70124‐8
D'Agostino RB Sr, Vasan RS, Pencina MJ, et al. General cardiovascular risk profile for use in primary care: the Framingham heart study. Circulation. 2008;117(6):743‐753.
Calvin CM, de Boer C, Raymont V, et al. Continuous and risk‐score‐based predictors of ATN Alzheimer's disease status among cognitively healthy individuals: findings from the EPAD‐LCS study [Internet]. Alzheimers Dement. 2020;16(S5):e041097. doi:10.1002/alz.041097
Lorenzini L, Ingala S, Wink AM, et al. The European prevention of Alzheimer's dementia (EPAD) MRI dataset and processing workflow [Internet]. bioRxiv 2021. doi:10.1101/2021.09.29.462349.abstract
Smith SM, Jenkinson M, Johansen‐Berg H, et al. Tract‐based spatial statistics: voxelwise analysis of multi‐subject diffusion data. NeuroImage. 2006;31(4):1487‐1505.
Wakana S, Jiang H, Nagae‐Poetscher LM, van Zijl PCM, Mori S. Fiber tract–based atlas of human white matter anatomy. Radiology. 2004;230(1):77‐87.
Aggleton JP, Nelson AJD, O'Mara SM. Time to retire the serial Papez circuit: implications for space, memory, and attention. Neurosci Biobehav Rev. 2022;140:104813.
Fortin J‐P, Cullen N, Sheline YI, et al. Harmonization of cortical thickness measurements across scanners and sites. NeuroImage. 2018;167:104‐120.
Oishi K, Lyketsos CG. Alzheimer's disease and the fornix. Front Aging Neurosci. 2014;6:241.
Alm KH, Bakker A. Relationships between diffusion tensor imaging and cerebrospinal fluid metrics in early stages of the Alzheimer's disease continuum. J Alzheimers Dis. 2019;70(4):965‐981.
Jacobs HIL, Hedden T, Schultz AP, et al. Structural tract alterations predict downstream tau accumulation in amyloid‐positive older individuals. Nat Neurosci. 2018;21(3):424‐431.
Collij LE, Ingala S, Top H, et al. White matter microstructure disruption in early stage amyloid pathology. Alzheimers Dement. 2021;13(1):e12124.
Lamar M, Boots EA, Arfanakis K, Barnes LL, Schneider JA. Common brain structural alterations associated with cardiovascular disease risk factors and Alzheimer's dementia: future directions and implications. Neuropsychol Rev. 2020;30(4):546‐557.
Vemuri P, Lesnick TG, Przybelski SA, et al. Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging. Ann Neurol. 2018;84(5):705‐716.
Gons RAR, van Oudheusden LJB, de Laat KF, et al. Hypertension is related to the microstructure of the corpus callosum: the RUN DMC study. J Alzheimers Dis. 2012;32(3):623‐631.
Tan X, Fang P, An J, et al. Micro‐structural white matter abnormalities in type 2 diabetic patients: a DTI study using TBSS analysis. Neuroradiology. 2016;58(12):1209‐1216.
Lorenzini L, Ansems LT, Lopes Alves I, et al. Regional associations of white matter hyperintensities and early cortical amyloid pathology. Brain Commun. 2022;4(3):fcac150.
Acosta‐Cabronero J, Alley S, Williams GB, Pengas G, Nestor PJ. Diffusion tensor metrics as biomarkers in Alzheimer's disease. PLoS One. 2012;7(11):e49072.
Caballero MÁA, Song Z, Rubinski A, et al. Age‐dependent amyloid deposition is associated with white matter alterations in cognitively normal adults during the adult life span. Alzheimers Dement. 2020;16(4):651‐661.
Weller RO, Boche D, Nicoll JAR. Microvasculature changes and cerebral amyloid angiopathy in Alzheimer's disease and their potential impact on therapy. Acta Neuropathol. 2009;118(1):87‐102.
Kisler K, Nelson AR, Montagne A, Zlokovic BV. Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci. 2017;18(7):419‐434.
Schneider JA, Arvanitakis Z, Bang W, Bennett DA. Mixed brain pathologies account for most dementia cases in community‐dwelling older persons. Neurology. 2007;69(24):2197‐2204.
Arfanakis K, Evia AM, Leurgans SE, et al. Neuropathologic correlates of white matter hyperintensities in a community‐based cohort of older adults. J Alzheimers Dis. 2020;73(1):333‐345.
Dewenter A, Jacob MA, Cai M, et al. Disentangling the effects of Alzheimer's and small vessel disease on white matter fibre tracts. Brain. 2023;146(2):678‐689.
Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat Rev Neurol. 2019;15(9):501‐518.
Liao F, Yoon H, Kim J. Apolipoprotein E metabolism and functions in brain and its role in Alzheimer's disease. Curr Opin Lipidol. 2017;28(1):60‐67.
Inoue Y, Shue F, Bu G, Kanekiyo T. Pathophysiology and probable etiology of cerebral small vessel disease in vascular dementia and Alzheimer's disease. Mol Neurodegener. 2023;18(1):46.
Falgàs N, Sánchez‐Valle R, Bargalló N, et al. Hippocampal atrophy has limited usefulness as a diagnostic biomarker on the early onset Alzheimer's disease patients: a comparison between visual and quantitative assessment. Neuroimage Clin. 2019;23:101927.
Lawrence KE, Nabulsi L, Santhalingam V, et al. Age and sex effects on advanced white matter microstructure measures in 15,628 older adults: a UK Biobank Study. Brain Imaging Behav. 2021;15(6):2813‐2823.
de Groot M, Cremers LGM, Ikram MA, et al. White matter degeneration with aging: longitudinal diffusion MR imaging analysis. Radiology. 2016;279(2):532‐541.
Wiegell MR, Larsson HB, Wedeen VJ. Fiber crossing in human brain depicted with diffusion tensor MR imaging. Radiology. 2000;217(3):897‐903.
Finger CE, Moreno‐Gonzalez I, Gutierrez A, Moruno‐Manchon JF, McCullough LD. Age‐related immune alterations and cerebrovascular inflammation. Mol Psychiatry. 2022;27(2):803‐818.
Luque Laguna PA, Combes AJE, Streffer J, et al. Reproducibility, reliability and variability of FA and MD in the older healthy population: a test‐retest multiparametric analysis. Neuroimage Clin. 2020;26:102168.